Physician profile
Adam Goodman
NPI 1609804558
$98,328.93
in general payments reported to CMS, 2019-2025
19 companies · $946 in 2025
The $946 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $2,764 · 2021: $21K · 2022: $22K · 2023: $34K · 2024: $18K · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $3,132 · Travel and Lodging: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,699.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,500.00 |
| Food and Beverage | $3,131.58 |
| Travel and Lodging | $1,810.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu A/S | $28,583.09 | 2020-2024 | |
| Ambu Innovation Gmbh | $26,687.72 | 2022-2023 | |
| Boston Scientific Corporation | $20,715.17 | 2020-2025 | Apollo Esg System, Resolution Clip, Axios |
| Ambu INC. | $18,908.99 | 2021-2025 | |
| Iterative Scopes, INC. | $1,237.52 | 2024 | Skout |
| Medtronic, INC. | $569.98 | 2021-2024 | Endoflip, Prodigi, Nexpowder |
| Pentax of America, INC. | $397.12 | 2022-2025 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
| Olympus America INC. | $208.88 | 2019-2025 | Single Use Repositionable Clip, Single Use Electrosurgical Knife Kd-655 |
| Abbvie INC. | $184.68 | 2025 | |
| Fujifilm Healthcare Americas Corporation | $181.78 | 2025 | |
| Novo Nordisk INC | $155.58 | 2024-2025 | Wegovy |
| Steris Corporation | $141.55 | 2024 | |
| Cook Medical LLC | $134.28 | 2019-2022 | |
| Conmed Corporation | $64.75 | 2019-2024 | Conmed Biliary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.15 | 2019-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $47.91 | 2020 | |
| Madrigal Pharmaceuticals | $24.18 | 2025 | Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.41 | 2024 | Xifaxan |
| Micro-Tech Endoscopy USA, INC. | $14.19 | 2024 | Dat Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.